Medical Diagnosis - Cancer Antigen 50 (CA 50)
Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability
Originalien CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis
Page 138 - Ghidul Serviciilor Medicale Synevo, Ediția 2, Volum 2
Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. - Abstract - Europe PMC
PDF) CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma
WO2012096862A1 - Vaccination of cancer patients - Google Patents
Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies.
Ca 50 Tumor Marker at Best Price in Shanghai | Tellgen Corporation
28 Ca125 Images, Stock Photos & Vectors | Shutterstock
Tumour Markers CA 19-9 and CA 50 in Digestive Tract Malignancies
A Systematic Review and Meta-Analysis of Diagnostic and Prognostic Serum Biomarkers of Colorectal Cancer | PLOS ONE
Medical Doctor on Instagram: “*Important TUMOR MARKERS . . . ❤️Love to TAG & SHARE @@doctordconli… | Medical knowledge, Doctor medical, Nursing school pharmacology
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. - Abstract - Europe PMC
Tumor Marker
Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar
![Sensitivity and specificity of important tumor markers [76] | Download Table](https://www.researchgate.net/publication/236093730/figure/tbl2/AS:393333642940428@1470789456330/Sensitivity-and-specificity-of-important-tumor-markers-76.png "Sensitivity and specificity of important tumor markers [76] | Download Table")
Sensitivity and specificity of important tumor markers [76] | Download Table
E. Henny Herningtyas Clinical Pathology Department, FM-UGM - ppt video online download
Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. - Abstract - Europe PMC
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. - Abstract - Europe PMC
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening
Layojat Nigeria - A tumor marker is a biomarker found in... | Facebook
CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease
CA 50 Blood Test | Blood Tests in London
Cancer Antigen 50 (CA-50), Human Tumor Marker
Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar
Sekbio CA 50 Tumor Marker, Cancer Antigen 50, CA 50 Marker Supplier
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50and CEA
